BIT:1ZTS - Euronext Milan - US98978V1035 - Common Stock - Currency: EUR
BIT:1ZTS (4/7/2025, 7:00:00 PM)
134.12
-21.16 (-13.63%)
The current stock price of 1ZTS.MI is 134.12 EUR.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
LLY.DE | ELI LILLY & CO | 53.68 | 624.44B | ||
1LLY.MI | ELI LILLY & CO | 52.54 | 611.17B | ||
ZEG.DE | ASTRAZENECA PLC | 18.34 | 374.68B | ||
JNJ.DE | JOHNSON & JOHNSON | 14.92 | 321.69B | ||
1JNJ.MI | JOHNSON & JOHNSON | 14.88 | 321.28B | ||
NOV.DE | NOVO NORDISK A/S-B | 19.51 | 266.79B | ||
RHO.DE | ROCHE HOLDING AG-BR | 14.61 | 236.62B | ||
SAN.PA | SANOFI | 13.66 | 225.12B | ||
SNW.DE | SANOFI | 13.36 | 220.06B | ||
1SAN.MI | SANOFI | 13.34 | 219.74B | ||
NOT.DE | NOVARTIS AG-REG | 13.06 | 190.69B | ||
6MK.DE | MERCK & CO. INC. | 9.62 | 168.22B |
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The company is headquartered in Parsippany, New Jersey and currently employs 13,800 full-time employees. The company went IPO on 2013-02-01. The firm is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The firm operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. The company directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. The firm is engaged in commercializing products across eight species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).
ZOETIS INC
10 Sylvan Way
Parsippany NEW JERSEY US
Employees: 14100
Phone: 19738227000
The current stock price of 1ZTS.MI is 134.12 EUR. The price decreased by -13.63% in the last trading session.
The exchange symbol of ZOETIS INC is 1ZTS and it is listed on the Euronext Milan exchange.
1ZTS.MI stock is listed on the Euronext Milan exchange.
24 analysts have analysed 1ZTS.MI and the average price target is 189.49 EUR. This implies a price increase of 41.29% is expected in the next year compared to the current price of 134.12. Check the ZOETIS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ZOETIS INC (1ZTS.MI) has a market capitalization of 59.83B EUR. This makes 1ZTS.MI a Large Cap stock.
ZOETIS INC (1ZTS.MI) currently has 14100 employees.
The Revenue of ZOETIS INC (1ZTS.MI) is expected to grow by 1.2% in the next year. Check the estimates tab for more information on the 1ZTS.MI EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ZOETIS INC (1ZTS.MI) has a dividend yield of 1.35%. The yearly dividend amount is currently 1.53. Check the full fundamental report for a detailed analysis of 1ZTS.MI dividend history, reliability and sustainability.
ZOETIS INC (1ZTS.MI) will report earnings on 2025-05-06, before the market open.
The PE ratio for ZOETIS INC (1ZTS.MI) is 25.74. This is based on the reported non-GAAP earnings per share of 5.21 and the current share price of 134.12 EUR. Check the full fundamental report for a full analysis of the valuation metrics for 1ZTS.MI.
ChartMill assigns a technical rating of 3 / 10 to 1ZTS.MI.
ChartMill assigns a fundamental rating of 6 / 10 to 1ZTS.MI. While 1ZTS.MI belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.
Over the last trailing twelve months 1ZTS.MI reported a non-GAAP Earnings per Share(EPS) of 5.21. The EPS increased by 11.28% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 26.86% | ||
ROA | 17.46% | ||
ROE | 52.12% | ||
Debt/Equity | 1.09 |
ChartMill assigns a Buy % Consensus number of 82% to 1ZTS.MI. The Buy consensus is the average rating of analysts ratings from 24 analysts.
For the next year, analysts expect an EPS growth of 4.39% and a revenue growth 1.2% for 1ZTS.MI